ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.54
0.00%
US Tech 100
20,642.00
-0.13%
S&P 500
5,941.97
-0.13%
US Dollar vs CAD
1.43808
0.38%
Bitcoin
98,346.94
-2.16%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Share Price

Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

USOTC
0.12
0.00
( 0.00% )
Updated: 18:00:00
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.12
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.35
Market Cap
14.445M
Previous Close
0.12
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
28,467
Shares Outstanding
120,377,529
Dividend Yield
-
PE Ratio
-2.52
Earnings Per Share (EPS)
-0.05
Revenue
35.43M
Net Profit
-5.74M

About Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.parnell.com
Headquarters
Sydney, New South Wales, Aus
Founded
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0.12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.35.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares outstanding. The market capitalization of Parnell Pharmaceuticals (CE) is US$14.45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

Ask ADVFN Intelligence (AI)

PARNF Latest News

More News

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

December 19 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

December 09 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

November 22 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

November 02 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

October 27 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

August 04 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

July 26 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

May 31 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

May 12 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

April 22 2016
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.120.120.125000.12CS
40.03846.34146341460.0820.180.082158690.14154906CS
120.071400.050.350.05284670.08767723CS
260.11991199000.00010.351.0E-6206910.08616385CS
520.119999119999001.0E-60.351.0E-6148680.08393423CS
1560.11991199000.00010.351.0E-6133440.02875162CS
2600.029933.18534961150.09010.891.0E-6124490.21523373CS

PARNF - Frequently Asked Questions (FAQ)

What is the current Parnell Pharmaceuticals (CE) share price?
The current share price of Parnell Pharmaceuticals (CE) is US$ 0.12
How many Parnell Pharmaceuticals (CE) shares are in issue?
Parnell Pharmaceuticals (CE) has 120,377,529 shares in issue
What is the market cap of Parnell Pharmaceuticals (CE)?
The market capitalisation of Parnell Pharmaceuticals (CE) is USD 14.45M
What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?
Parnell Pharmaceuticals (CE) has traded in the range of US$ 0.000001 to US$ 0.35 during the past year
What is the PE ratio of Parnell Pharmaceuticals (CE)?
The price to earnings ratio of Parnell Pharmaceuticals (CE) is -2.52
What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?
The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0.41
What is the reporting currency for Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) reports financial results in AUD
What is the latest annual turnover for Parnell Pharmaceuticals (CE)?
The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35.43M
What is the latest annual profit for Parnell Pharmaceuticals (CE)?
The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5.74M
What is the registered address of Parnell Pharmaceuticals (CE)?
The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
What is the Parnell Pharmaceuticals (CE) website address?
The website address for Parnell Pharmaceuticals (CE) is www.parnell.com
Which industry sector does Parnell Pharmaceuticals (CE) operate in?
Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EARIEntertainment Arts Research Inc (PK)
US$ 0.00014
(13,900.00%)
432.16k
INTKIndustrial Nanotech Inc (PK)
US$ 0.0001
(9,900.00%)
6.1M
DECNDecision Diagnostics Corporation (CE)
US$ 0.0001
(9,900.00%)
2.24M
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0.0001
(9,900.00%)
2.03M
BSNLFBlue Star Helium Ltd (PK)
US$ 0.01
(9,900.00%)
4k
MRNJMetatron Inc (PK)
US$ 0.000001
(-99.00%)
892.73k
HBRMHerborium Group Inc (PK)
US$ 0.000001
(-99.00%)
101k
BRGOBergio International Inc (PK)
US$ 0.000001
(-99.00%)
500.32k
ZRFYZerify Inc (CE)
US$ 0.000001
(-99.00%)
12.64k
MTEMMolecular Templates Inc (PK)
US$ 0.001
(-93.33%)
200
RDARRaadr Inc (PK)
US$ 0.0014
(21.74%)
82.92M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(-50.00%)
69.71M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
41.6M
HMBLHUMBL Inc (PK)
US$ 0.00095
(-5.00%)
33.94M
GMZPGemz Corporation (PK)
US$ 0.0002
(0.00%)
29.53M

Discussion

View Full Feed
wingnutt01 wingnutt01 3 minutes ago
And now you know the rest of the story.
FMCC
4retire 4retire 3 minutes ago
Motley Fool is TRASH.
NVDA
Doubledown75 Doubledown75 3 minutes ago
Fxy going to pull SPY up;)
SPY
i_like_bb_stock i_like_bb_stock 3 minutes ago
yea the odd thing is there has been no dilution inn years when it was trading
FUTS
Seriously folks Seriously folks 3 minutes ago
Is NVDA involved with BZAI ?
NVDA
glenn1919 glenn1919 3 minutes ago
SOBR......TNXP......GORO.......ACON.......https://stockcharts.com/h-sc/ui?s=SOBR&p=D&yr=0&mn=2&dy=12&id=p84071410134
ACON GORO SOBR
deri21 deri21 4 minutes ago
$KAYS Kaya Holdings, Inc. (OTCQB:KAYS): The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization Program
https://www.accessnewswire.com/newsroom/en/agriculture/kaya-holdings-inc-otcqbkays-the-sacred-mushroom-oregons-premier-psilo
KAYS
HGilS HGilS 4 minutes ago
I think NAS means to say - if we have $1 Million to spend, better spend it on R&D than spend it on Buying shares back - i.e. growing the value of the company - which is substantial - while the PPS/Number of shares is subject to manipulation and at the end of the day you are left with the same assets
ELTP
BullNBear52 BullNBear52 4 minutes ago
Wouldn't surprise me if Musk buys TikTok instead.
saigai saigai 4 minutes ago
svmh..i dont get it.. what was the point of a 50/1 rs to comply with nasdaq review ..if you dont have milestones/news to support it..sorry for the bad suggesstion..
vlispxpert vlispxpert 4 minutes ago
out ARQQ +$10 ;)
ARQQ
DP1011 DP1011 4 minutes ago
Time to wait for the next flip. I'll only buy 1 and 2's. 
PHIL
NoMoDo NoMoDo 4 minutes ago
Nothing. Was very surprised that they didn't put out a PR or an 8k last night or this morning. Maybe they were still working out last minute stuff, but if that were the case, a simple tweet on x could have simply said, that they are working on final details, cannot give speak on the subject yet, w
HMBL
ergo sum ergo sum 4 minutes ago
David Brooks.
Now, if you are holding hearings for a prospective secretary of defense, you would think you might want to ask him about these urgent issues. Or you might come up with other serious questions: How do drones change war-fighting? How will artificial intelligence alter the nature o
manibiotech manibiotech 4 minutes ago
Agree
Spoofing and manipulation as I have said doesn't block people from buying more . That has not shown in volume for a lonnng time . So that's not the only reason for depressed SP which usual few refuse to admit /acknowledge for whatever motives 
NWBO
rooster rooster 4 minutes ago
https://x.com/libertypillmeme/status/1879887432109404207?s=46&t=qLQnO1TjeygtFbhEqQdlmg
Donotunderstand Donotunderstand 4 minutes ago
?
what did Ackman say about rights offering ?

I am not listening or reading - is that offering shares the GOV gets from exercising warrants ? or is that some new added dilution ?

thank you
FNMA
mailman69 mailman69 4 minutes ago
I agree!!!!
VXIT
i_like_bb_stock i_like_bb_stock 4 minutes ago
yea no one is green on his thing
AFFU
Risk vs Reward Risk vs Reward 5 minutes ago
She's churning ....
KULR
TenKay TenKay 5 minutes ago
It’s basically the same announcement HMBL made in early December about the deal with YBYRA.

What makes that particularly interesting?
HMBL
Doubledown75 Doubledown75 5 minutes ago
Yes it's not like the guy left and ain't talking anymore lol
People all require attention;)
I think the 2021 volume will come back, otc will be lit and bashers will be quiet as a mouse.
It's pretty simple. Revolving credit, liquidity. The choices are default or print and it real
AABB
firebag1 firebag1 5 minutes ago
when you least expect it expect it lol - no not what was hoped for but that was yesterday...stock is still trading strong....maybe today
HMBL
3antar 3antar 5 minutes ago
Ok Bill! Sheesh
FNMA
tw0122 tw0122 5 minutes ago
$2.72 gone green offering absorbed now. Let's see what happens next $6- $8 targets 
PHIO

Your Recent History

USOTC
PARNF
Parnell Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads